QID 316988

Date Published: 2021-07-06

QID 316988: Cisco ESA, SMA,WSA Lasso SAML Implementation Vulnerability (cisco-sa-lasso-saml-jun2021-DOXNRLkD)

On June 1, 2021, Lasso disclosed a security vulnerability in the Lasso Security Assertion Markup Language (SAML) Single Sign-On (SSO) library.

Affected Products
1.Cisco Content Security Management Appliance (SMA)
Affected feature: Web-based management interface (only when SSO is enabled)
Affected Version:
Prior to 13.8.1
From 14.0 Prior to 14.1.0
2.Cisco Email Security Appliance (ESA)
Affected feature: Web-based management interface (only when SSO is enabled)
Affected Version: Prior to 14.0.0-692
3.Cisco Web Security Appliance (WSA) Prior to 14.0.1 (Sep 2021)
Note: Potential detection as cannot confirm Single Sign On (SSO) feature is enabled.

QID Detection Logic (Authenticated):
The Qid checks for the Vulnerable version of Cisco ESA,CSM,WSA in the response of "version" command.

This vulnerability could allow an authenticated attacker to impersonate another authorized user when interacting with an application.

  • CVSS V3 rated as High - 7.5 severity.
  • CVSS V2 rated as Medium - 5 severity.
    • Solution

    Customers are advised to refer to cisco-sa-lasso-saml-jun2021-DOXNRLkD for more information.

    Vendor References

    CVEs related to QID 316988

    CVE-2021-28091 |
    Software Advisories
    Advisory ID Software Component Link
    cisco-sa-lasso-saml-jun2021-DOXNRLkD URL Logo tools.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-lasso-saml-jun2021-DOXNRLkD
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].